Abramson Cancer Center
Brentuximab Vedotin and Chemotherapy in CD30+ PMBL, Diffuse Large B-Cell, and Grey Zone Lymphoma Patients
- Conditions
- CD30 Positive Primary Mediastinal Large B-cell LymphomaCD30-Positive Diffuse Large B-Cell LymphomaCD30-Positive Gray Zone Lymphoma
- Interventions
- First Posted Date
- 2013-11-26
- Last Posted Date
- 2021-01-05
- Lead Sponsor
- Abramson Cancer Center at Penn Medicine
- Target Recruit Count
- 32
- Registration Number
- NCT01994850
- Locations
- 🇺🇸
Abramson Cancer Center of the University of Pennsylvania, Philadelphia, Pennsylvania, United States
Suitability of DCE-MRI for Detection of Vascular Changes After VBT
- Conditions
- Carcinoma of the Cervix, Carcinoma or Carcinosarcoma of the Uterus
- Interventions
- Radiation: Radiotherapy
- First Posted Date
- 2013-11-25
- Last Posted Date
- 2019-11-26
- Lead Sponsor
- Abramson Cancer Center at Penn Medicine
- Target Recruit Count
- 16
- Registration Number
- NCT01991808
- Locations
- 🇺🇸
Abramson Cancer Center of the University of Pennsylvania, Philadelphia, Pennsylvania, United States
Functional MRI Use in Prostate Radiation Treatment Planning
- Conditions
- Prostate Cancer
- Interventions
- Device: MRI
- First Posted Date
- 2013-11-18
- Last Posted Date
- 2019-11-26
- Lead Sponsor
- Abramson Cancer Center at Penn Medicine
- Target Recruit Count
- 15
- Registration Number
- NCT01985932
- Locations
- 🇺🇸
Abramson Cancer Center of the University of Pennsylvania, Philadelphia, Pennsylvania, United States
A Pilot Study to Evaluate Radiotherapy-Induced Anti-Tumor Immunity in Metastatic Carcinoma of the Pancreas
- Conditions
- Histological or Cytological Diagnosis of Pancreatic Carcinoma
- Interventions
- Device: Radiation therapy
- First Posted Date
- 2013-11-18
- Last Posted Date
- 2020-04-20
- Lead Sponsor
- Abramson Cancer Center at Penn Medicine
- Target Recruit Count
- 4
- Registration Number
- NCT01985958
- Locations
- 🇺🇸
Abramson Cancer Center of the University of Pennsylvania, Philadelphia, Pennsylvania, United States
Yoga for Breast Cancer
- Conditions
- Women With Stage I or II Breast Cancer Undergoing Active Radiation Therapy
- Interventions
- Other: Yoga
- First Posted Date
- 2013-11-18
- Last Posted Date
- 2020-03-11
- Lead Sponsor
- Abramson Cancer Center at Penn Medicine
- Target Recruit Count
- 70
- Registration Number
- NCT01985945
- Locations
- 🇺🇸
Abramson Cancer Center of the University of Pennsylvania, Philadelphia, Pennsylvania, United States
Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples
- Conditions
- No Restrictions on Diagnosis
- Interventions
- Other: Obtaining human tissue for basic research or biospecimen bank
- First Posted Date
- 2013-11-18
- Last Posted Date
- 2024-06-18
- Lead Sponsor
- Abramson Cancer Center at Penn Medicine
- Target Recruit Count
- 150
- Registration Number
- NCT01985919
- Locations
- 🇺🇸
Abramson Cancer Center of the University of Pennsylvania, Philadelphia, Pennsylvania, United States
F18 EF5 PET/CT Imaging in Patients With Brain Metastases From Breast Cancer
- Conditions
- Brain Metastases From Breast Cancer
- Interventions
- Radiation: PET/CT Imaging
- First Posted Date
- 2013-11-18
- Last Posted Date
- 2020-01-31
- Lead Sponsor
- Abramson Cancer Center at Penn Medicine
- Target Recruit Count
- 2
- Registration Number
- NCT01985971
- Locations
- 🇺🇸
Abramson Cancer Center of the University of Pennsylvania, Philadelphia, Pennsylvania, United States
HPV Serum DNA Levels Predicting Outcome in p16+ Squamous Cell Head and Neck Cancer
- Conditions
- Subjects With p16 Positive/HPV Positive Squamous Cell Carcinomas of the Oropharynx
- Interventions
- Other: Obtaining Human tissue
- First Posted Date
- 2013-11-14
- Last Posted Date
- 2020-04-10
- Lead Sponsor
- Abramson Cancer Center at Penn Medicine
- Target Recruit Count
- 80
- Registration Number
- NCT01984359
- Locations
- 🇺🇸
Abramson Cancer Center of the University of Pennsylvania, Philadelphia, Pennsylvania, United States
Study Of Circulating Multiple Myeloma Cells As A Biomarker of MGUS And SMM
- Conditions
- a Diagnosis of MGUS or SMM by IMWG Criteria
- First Posted Date
- 2013-10-09
- Last Posted Date
- 2022-05-20
- Lead Sponsor
- Abramson Cancer Center at Penn Medicine
- Target Recruit Count
- 52
- Registration Number
- NCT01958528
- Locations
- 🇺🇸
Abramson Cancer Center of the University of Pennsylvania, Philadelphia, Pennsylvania, United States
TACE With or Without SBRT as Bridging Therapy for Pre-transplant HCC Patients
- Conditions
- Hepatocellular Carcinoma
- Interventions
- Radiation: TACE transarterial chemoembolizationRadiation: stereotatic body radiotherapy (SBRT)
- First Posted Date
- 2013-08-08
- Last Posted Date
- 2025-01-28
- Lead Sponsor
- Abramson Cancer Center at Penn Medicine
- Target Recruit Count
- 40
- Registration Number
- NCT01918683
- Locations
- 🇺🇸
Oregon Health & Science University, Portland, Oregon, United States
🇺🇸Loyola University Medical Center, Maywood, Illinois, United States
🇺🇸Abramson Cancer Center of the University of Pennsylvania, Philadelphia, Pennsylvania, United States